Neuropsychiatric Systemic Lupus Erythematosus Presenting as Mania With Psychosis Treated Successfully With Intravenous Immunoglobulin: A Diagnosis of Associations and Exclusions

David R. Spiegel, MD; Abbey McLean, MD; Nina L. Swiacki, MD; Joshua Moran, DO

Prim Care Companion CNS Disord 2022;24(2):21cr02969

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login

Purchase PDF for $40

Members enjoy free PDF downloads on all articles. Join today

References (17)

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42(4):599–608. PubMed CrossRef
Meszaros ZS, Perl A, Faraone SV. Psychiatric symptoms in systemic lupus erythematosus: a systematic review. J Clin Psychiatry. 2012;73(7):993–1001. PubMed CrossRef
Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133(5):429–435. PubMed CrossRef
Hanly JG, Li Q, Su L, et al. Psychosis in systemic Lupus Erythematosus: results from an International Inception Cohort Study. Arthritis Rheumatol. 2019;71(2):281–289. PubMed CrossRef
Ainiala H, Hietaharju A, Loukkola J, et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum. 2001;45(5):419–423. PubMed CrossRef
Popescu A, Kao AH. Neuropsychiatric systemic lupus erythematosus. Curr Neuropharmacol. 2011;9(3):449–457. PubMed CrossRef
Joo YB, Park SY, Won S, et al. Differences in clinical features and mortality between childhood-onset and adult-onset systemic Lupus Erythematosus: a prospective single-center study. J Rheumatol. 2016;43(8):1490–1497. PubMed CrossRef
Arinuma Y, Yamaoka K. Developmental process in diffuse psychological/neuropsychiatric manifestations of neuropsychiatric systemic lupus erythematosus. Immunol Med. 2021;44(1):16–22. PubMed CrossRef
Nikolopoulos D, Fanouriakis A, Boumpas DT. Update on the pathogenesis of central nervous system lupus. Curr Opin Rheumatol. 2019;31(6):669–677. PubMed CrossRef
Cozzani E, Drosera M, Gasparini G, et al. Serology of Lupus Erythematosus: correlation between immunopathological features and clinical aspects. Autoimmune Dis. 2014;2014:321359. PubMed CrossRef
Lim SS, Drenkard C. Epidemiology of lupus: an update. Curr Opin Rheumatol. 2015;27(5):427–432. PubMed
Forrester A, Latorre S, O’Dea PK, et al. Anti-NMDAR Encephalitis: a multidisciplinary approach to identification of the disorder and management of psychiatric symptoms. Psychosomatics. 2020;61(5):456–466. PubMed CrossRef
Bhangle SD, Kramer N, Rosenstein ED. Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus. Rheumatol Int. 2013;33(8):1923–1932. PubMed CrossRef
Bellivier F, Golmard JL, Rietschel M, et al. Age at onset in bipolar I affective disorder: further evidence for three subgroups. Am J Psychiatry. 2003;160(5):999–1001. PubMed CrossRef
Akinhanmi MO, Biernacka JM, Strakowski SM, et al. Racial disparities in bipolar disorder treatment and research: a call to action. Bipolar Disord. 2018;20(6):506–514. PubMed CrossRef
Milstone AM, Meyers K, Elia J. Treatment of acute neuropsychiatric lupus with intravenous immunoglobulin (IVIG): a case report and review of the literature. Clin Rheumatol. 2005;24(4):394–397. PubMed CrossRef
Brogna C, Manna R, Contaldo I, et al. Intravenous immunoglobulin for pediatric neuropsychiatric lupus triggered by Epstein-Barr Virus cerebral infection. Isr Med Assoc J. 2016;18(12):763–766. PubMed